ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era

Chen, Juanjuan; Wu, Yihua; Kang, Zixin; Qin, Shanfang; Ruan, Guangjing; Zhao, Han; Tao, Xin; Xie, Zhiman*; Peng, Jie*广州医学院; 南方医科大学; 1
Cancer Medicine2023-6DOI: 10.1002/cam4.5957
6閱讀
引用收藏
分享

摘要

BackgroundOptimization of risk stratification is important for facilitating prognoses and therapeutic decisions regarding diffuse large B-cell lymphoma (DLBCL). However, a simple and applicable prognostic tool is lacking for individuals with human immunodeficiency virus (HIV)-related DLBCL in the era of combined antiretroviral therapy (cART). MethodsThis retrospective multicenter observational study included 147 HIV-related DLBCL patients with histologically confirmed DLBCL from 2013 to 2020. The total group was divided into training (n = 78) and validation (n = 69) cohorts to derive the best prognostic score. Clinicopathological and characteristic biomarkers correlated with clinical outcomes were analyzed. ResultsAge, Ann Arbor stage, lactate dehydrogenase (LDH) ratio, bulky disease, and red blood cell distribution width (RDW) ratio retained robust independent correlations with overall survival (OS) in multivariate analysis. A new and practical prognostic model was generated and externally validated, classifying patients into three categories with significantly different survival rates. Moreover, the new index outperformed the International Prognostic Index (IPI) score (area under the curve values of 0.94 vs. 0.81 in the training cohort and 0.85 vs. 0.74 in the validation cohort, C-indices of 0.80 vs. 0.70 in the training cohort and 0.74 vs. 0.70 in the validation cohort, and integrated discrimination improvement values of 0.203 in the training cohort and 0.175 in the validation cohort) and was better at defining intermediate- and high-risk groups. The calibration curves performed satisfactorily for predicting 3-year OS in the training and validation cohorts. ConclusionsWe developed and validated a simple and feasible prognostic model for patients with HIV-related DLBCL that had more discriminative and predictive accuracy than the IPI score for risk stratification and individualized treatment in the cART era.

學科與關鍵詞

關鍵詞
diffuse large B-cell lymphomahuman immunodeficiency virusoverall survivalprognostic modelred blood cell distribution width ratio
相關
載入中…
  • A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma
    Chen, Juanjuan*; Liu, Xuewu; Qin, Shanfang; Ruan, Guangjing; Lu, Aili; Zhang, Jinxin; Wu, Yihua; Xie, Zhiman*; Peng, Jie*Frontiers in Cellular and Infection Microbiology, 2022, 12: 919446.被引 1
  • A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
    Cai, Jun; Tian, Xiaopeng; Ma, Shuyun; Zhong, Liye; Li, Wenyu; Wang, Liang; Guo, Linlang; Li, Zhihua; Wu, Yudan; Zhong, Guangzheng; Huang, Huiqiang; Xia, Zhongjun; Xia, Yi; Liu, Panpan; Su, Ning; Fang, Yu; Zhang, Yuchen; Cai, Qingqing*British Journal of Cancer, 2021, 125(3): 402-412.被引 4
  • Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma
    Chen, Qiushi; Ayer, Turgay; Nastoupil, Loretta J.; Koff, Jean L.; Staton, Ashley D.; Chhatwal, Jagpreet; Flowers, Christopher R.*LEUKEMIA & LYMPHOMA, 2016, 57(4): 842-851.被引 8
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Cancer Medicine
發表日期
2023-06
卷期
第 12 卷, 第 11 期
頁碼
12470-12481
DOI
10.1002/cam4.5957
語言
ENGLISH
成果收錄
SCIE

作者

  • C

    Chen, Juanjuan (第一作者)

    southern med univ

  • W

    Wu, Yihua

    southern med univ

查看全部 9 位作者收起作者
  • K

    Kang, Zixin

    southern med univ

  • Q

    Qin, Shanfang

    hosp guangxi zhuang autonomous reg

  • R

    Ruan, Guangjing

  • Z

    Zhao, Han

    southern med univ · guangzhou med univ

  • T

    Tao, Xin

    southern med univ

  • X

    Xie, Zhiman (通訊)

    1

  • P

    Peng, Jie (通訊)

    southern med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417